# Diasome Pharmaceuticals funding: rounds and investors

> Diasome Pharmaceuticals has raised $9.0M across 1 round since 2023. Every round with its source.

Source: https://millionrounds.com/company/diasome-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article)

United States · [Venture startup](https://millionrounds.com/companies)

# Who invested in *Diasome Pharmaceuticals*

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Follow Diasome Pharmaceuticals and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2Fdiasome-pharmaceuticals)

Funding summary Updated 15 Nov 2026

**$9.0M** raised across 1 round since 2023, from 1 source

- **Latest round:** Venture, $9.0M Jun 2023
- **Investors:** 0

See who backed them

## The rounds

- **Jun 2023** Venture **$9.0M** No investor was named in the report. Source recorded SEC filing: $9.0M sold, first sale Jun 2023

## Funding filed with regulators

Diasome Pharmaceuticals filed 8 raises, $63M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Jul 2024 **$3.1M** 4 investors of $16M offered SEC Form D
- Jun 2023 **$9.0M** 2 investors equity of $15M offered SEC Form D
- Aug 2022 **$17M** 40 investors equity of $19M offered SEC Form D
- Sept 2020 **$1.5M** 6 investors debt, options of $5.0M offered SEC Form D
- Mar 2020 **$2.9M** 20 investors equity of $2.9M offered SEC Form D
- Oct 2018 **$12M** 22 investors debt of $19M offered SEC Form D
- Dec 2016 **$4.3M** 4 investors debt of $8.0M offered SEC Form D
- Mar 2008 **$13M** 9 investors equity, debt of $13M offered SEC Form D

## Founders and team

From Diasome Pharmaceuticals's own website: 5 on the team.

- **J. Lincoln Chapin** Vice President of Clinical Operations
- **Linda Rubinstein** Chief Financial Officer
- **Eric Edidin** Board Chairman
- **Frank McCaney** Director
- **Thomas McDonald** Director

## Quick answers about Diasome Pharmaceuticals

### How much has Diasome Pharmaceuticals raised?

Diasome Pharmaceuticals has raised $9.0M across 1 round since 2023.

### When did Diasome Pharmaceuticals last raise?

Diasome Pharmaceuticals's most recent round was a Venture of $9.0M in Jun 2023.

### What was Diasome Pharmaceuticals's biggest round?

Its most recent round, $9.0M in Jun 2023, is also its largest on record.

### What stage is Diasome Pharmaceuticals at?

Diasome Pharmaceuticals's latest named round is a Venture, in Jun 2023.

### Where is Diasome Pharmaceuticals based?

Diasome Pharmaceuticals is based in the United States.

## Companies like Diasome Pharmaceuticals

In the same sector, and raised in the last eighteen months.

[**Neuvivo** $1.4M · Nov 2026](https://millionrounds.com/company/neuvivo)[**Mirendil** $1.4B · Nov 2026](https://millionrounds.com/company/mirendil)[**Nanopath** $25M · Nov 2026](https://millionrounds.com/company/nanopath)[**InSitu Biologics** $22M · Nov 2026](https://millionrounds.com/company/insitu-biologics)[**Frontier Bio** $1.7M · Nov 2026](https://millionrounds.com/company/frontier-bio)[**CARI Health** $3.1M · Nov 2026](https://millionrounds.com/company/cari-health)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app